Partners Capital Investment Group LLP Has $278,000 Holdings in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)

Partners Capital Investment Group LLP lessened its holdings in shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) by 50.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 12,917 shares of the company’s stock after selling 12,916 shares during the quarter. Partners Capital Investment Group LLP’s holdings in Invesco Nasdaq Biotechnology ETF were worth $278,000 as of its most recent filing with the Securities & Exchange Commission.

Separately, Mirae Asset Global Investments Co. Ltd. increased its position in Invesco Nasdaq Biotechnology ETF by 22.7% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock worth $6,156,000 after buying an additional 48,137 shares during the last quarter.

Invesco Nasdaq Biotechnology ETF Stock Down 0.2 %

Shares of NASDAQ IBBQ opened at $22.58 on Monday. Invesco Nasdaq Biotechnology ETF has a twelve month low of $20.14 and a twelve month high of $24.84. The company has a market cap of $39.97 million, a PE ratio of 17.39 and a beta of 0.61. The business’s 50 day moving average price is $22.09 and its two-hundred day moving average price is $23.11.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 23rd were issued a dividend of $0.0619 per share. The ex-dividend date of this dividend was Monday, December 23rd.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.